The effect of high-density lipoprotein (HDL) in protecting against atherosclerosis is usually attributed to its role in ‘reverse cholesterol transport’1. In this process, HDL particles mediate the efflux and the transport of cholesterol from peripheral cells to the liver for further metabolism and bile excretion. Thus, cell-surface receptors for HDL on hepatocytes are chief partners in the regulation of cholesterol homeostasis2. A high-affinity HDL receptor for apolipoprotein A-I (apoA-I) was previously identified on the surface of hepatocytes3,4. Here we show that this receptor is identical to the β-chain of ATP synthase, a principal protein complex of the mitochondrial inner membrane. Different experimental approaches confirm this ectopic localization of components of the ATP synthase complex and the presence of ATP hydrolase activity at the hepatocyte cell surface. Receptor stimulation by apoA-I triggers the endocytosis of holo-HDL particles (protein plus lipid) by a mechanism that depends strictly on the generation of ADP. We confirm this effect on endocytosis in perfused rat liver ex vivo by using a specific inhibitor of ATP synthase. Thus, membrane-bound ATP synthase has a previously unsuspected role in modulating the concentrations of extracellular ADP and is regulated by a principal plasma apolipoprotein.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Sviridov, D. & Nestel, P. Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 161, 245–254 (2002)
Fidge, N. H. High density lipoprotein receptors, binding proteins, and ligands. J. Lipid Res. 40, 187–201 (1999)
Barbaras, R., Collet, X., Chap, H. & Perret, B. Specific binding of free apolipoprotein A-I to a high-affinity binding site on HepG2 cells: characterization of two high-density lipoprotein sites. Biochemistry 33, 2335–2340 (1994)
Martinez, L. O. et al. Characterization of two high-density lipoprotein binding sites on porcine hepatocyte plasma membranes: contribution of scavenger receptor class B type I (SR-BI) to the low-affinity component. Biochemistry 39, 1076–1082 (2000)
Boyer, P. D. The ATP synthase: a splendid molecular machine. Annu. Rev. Biochem. 66, 717–749 (1997)
Stock, D., Leslie, A. G. & Walker, J. E. Molecular architecture of the rotary motor in ATP synthase. Science 286, 1700–1705 (1999)
Cabezon, E., Runswick, M. J., Leslie, A. G. & Walker, J. E. The structure of bovine IF(1), the regulatory subunit of mitochondrial F-ATPase. EMBO J. 20, 6990–6996 (2001)
Das, B., Mondragon, M. O., Sadeghian, M., Hatcher, V. B. & Norin, A. J. A novel ligand in lymphocyte-mediated cytotoxicity: expression of the beta subunit of H + transporting ATP synthase on the surface of tumour cell lines. J. Exp. Med. 180, 273–281 (1994)
Moser, T. L. et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Natl Acad. Sci. USA 96, 2811–2816 (1999)
Chang, S. Y., Park, S. G., Kim, S. & Kang, C. Y. Interaction of the C-terminal domain of p43 and the α subunit of ATP synthase: Its functional implication in endothelial cell proliferation. J. Biol. Chem. 277, 8388–8394 (2001)
Schippers, I. J. et al. Immortalized human hepatocytes as a tool for the study of hepatocytic (de-)differentiation. Cell Biol. Toxicol. 13, 375–86 (1997)
Williams, N., Amzel, L. M. & Pedersen, P. L. Proton ATPase of rat liver mitochondria: a rapid procedure for purification of a stable, reconstitutively active F1 preparation using a modified chloroform method. Anal. Biochem. 140, 581–588 (1984)
Moser, T. L. et al. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc. Natl Acad. Sci. USA 98, 6656–6661 (2001)
Beisiegel, U. et al. Apolipoprotein E-binding proteins isolated from dog and human liver. Arteriosclerosis 8, 288–297 (1988)
Mahley, R. W., Hui, D. Y., Innerarity, T. L. & Beisiegel, U. Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake. Arteriosclerosis 9, I14–I18 (1989)
Ferrini, J. B., Pichard, L., Domergue, J. & Maurel, P. Long-term primary cultures of adult human hepatocytes. Chem. Biol. Interact. 107, 31–45 (1997)
Cabezon, E., Arechaga, I., Jonathan, P., Butler, G. & Walker, J. E. Dimerization of bovine F1-ATPase by binding the inhibitor protein, IF1 . J. Biol. Chem. 275, 28353–28355 (2000)
Cabezon, E., Butler, P. J., Runswick, M. J. & Walker, J. E. Modulation of the oligomerization state of the bovine F1-ATPase inhibitor protein, IF1, by pH. J. Biol. Chem. 275, 25460–25464 (2000)
Guendouzi, K., Collet, X., Perret, B., Chap, H. & Barbaras, R. Remnant high density lipoprotein2 particles produced by hepatic lipase display high-affinity binding and increased endocytosis into a human hepatoma cell line (HEPG2). Biochemistry 37, 14974–14980 (1998)
Acton, S. et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271, 518–520 (1996)
Silver, D. L., Nan, W., Xiao, X. & Tall, A. R. HDL particle uptake mediated by SR-BI results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J. Biol. Chem. 276, 25287–25293 (2001)
Walker, J. E. The regulation of catalysis in ATP synthase. Curr. Opin. Struct. Biol. 4, 912–918 (1994)
Wang, N., Silver, D. L., Thiele, C. & Tall, A. R. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 276, 23742–23747 (2001)
Bortnick, A. E. et al. The correlation of ABC1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. 275, 28634–28640 (2000)
Burgess, J. W., Kiss, R. S., Zheng, H., Zachariah, S. & Marcel, Y. L. Trypsin-sensitive and lipid-containing sites of the macrophage extracellular matrix bind apolipoprotein A-I and participate in ABCA1-dependent cholesterol efflux. J. Biol. Chem. 277, 31318–31326 (2002)
Fitzgerald, M. L. et al. Naturally occurring mutations in ABCA1's largest extracellular loops can disrupt its direct interaction with apolipoprotein A-I. J. Biol. Chem. 277, 33178–33187 (2002)
Barrans, A. et al. Hepatic lipase induces the formation of pre-β1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2 . J. Biol. Chem. 269, 11572–11577 (1994)
Johnsson, B., Lofas, S. & Lindquist, G. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem. 198, 268–277 (1991)
Sultan, C. et al. The novel inositol lipid phosphatidylinositol 3,4-bisphosphate is produced by human blood platelets upon thrombin stimulation. Biochem. J. 269, 831–834 (1990)
We thank G. Larrieu, for technical help, and P. Maurel INSERMU128, for the primary human hepatocytes.
The authors declare that they have no competing financial interests.
About this article
Cite this article
Martinez, L., Jacquet, S., Esteve, J. et al. Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature 421, 75–79 (2003). https://doi.org/10.1038/nature01250
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
Advanced Drug Delivery Reviews (2020)
Advanced Drug Delivery Reviews (2020)
Clinica Chimica Acta (2020)
A reference measurement of circulating ATPase inhibitory factor 1 (IF1) in humans by LC-MS/MS: Comparison with conventional ELISA
Serum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: The GENES study
Scientific Reports (2020)